A bone sarcoma is a primary malignant tumour of bone, and it is rare enough that a general practitioner may never see one. The ST3 interview does not test its treatment. It tests whether you recognise the red flags, refer to a bone sarcoma centre, and keep your needle out of the tumour.
Key takeaways
- The British Sarcoma Group states that bone pain at night should always be considered a red flag requiring further investigation, and that pain or a palpable mass arising from any bone requires investigation.
- Four X-ray features are suggestive but not diagnostic of a primary bone tumour: bone destruction, new bone formation, periosteal reaction or swelling, and soft tissue swelling.
- The June 2022 BOA Standard requires referral to a bone sarcoma centre within 72 hours of the first suspicious or diagnostic imaging, and states biopsy must be performed at that centre.
- NICE NG12 asks for a very urgent referral, meaning an appointment within 48 hours, for a child or young person whose X-ray suggests the possibility of bone sarcoma, and a suspected cancer pathway referral for an adult.
- The British Sarcoma Group records an average symptom duration of 3 months before diagnosis, with 6 months or longer not uncommon, and 5-year survival static at 53% to 55%.
- A normal X-ray does not exclude a bone sarcoma: the British Sarcoma Group states that persistent bone pain or night pain should still prompt urgent MRI or referral.
What is a bone sarcoma and who gets one?
A bone sarcoma is a primary malignant tumour arising from bone, as distinct from a metastasis or a haematological malignancy in bone, which are far more common in adults over 40.
The British Sarcoma Group records that primary malignant bone tumours make up 0.2% of all cancers diagnosed in England, with an annual incidence of around 7.9 per million.
The same guideline reports that an average of 380 people a year were diagnosed with a primary bone sarcoma in England between 1985 and 2009, so a general practitioner is unlikely to see one in a working lifetime.
Osteosarcoma accounts for over 10% of all solid cancers in adolescents aged 15 to 19, usually arises in the metaphysis of a long bone around the knee, and has a second peak in the seventh and eighth decades.
Ewing sarcoma has a median age at diagnosis of around 15 years, while chondrosarcoma typically presents between 30 and 60 and, with an ageing population, has become the commonest bone sarcoma in the UK.
What are the red flags for a bone sarcoma?
The red flag for a bone sarcoma is pain, particularly night pain. The British Sarcoma Group states that bone pain at night should always be considered a red flag symptom requiring further investigation.
The same guideline states that the presence of pain or a palpable mass arising from any bone requires further investigation, and that pain may gradually increase or vary in intensity.
Delay is the pattern to recognise. The British Sarcoma Group records an average symptom duration of 3 months before diagnosis, with 6 months or longer not uncommon.
Two traps are named explicitly. A recent injury does not rule out a primary bone tumour, and a normal X-ray does not either, particularly around the hip and knee in children where pain is blamed on sport.
Systemic symptoms are unusual in bone sarcoma, and the British Sarcoma Group notes that when they are present they may indicate metastatic disease rather than argue against the diagnosis.
What does NICE NG12 say about referral for a suspected bone sarcoma?
NICE NG12 splits bone sarcoma referral by age. For adults, it says to consider a suspected cancer pathway referral if an X-ray suggests the possibility of bone sarcoma.
For children and young people, NG12 asks you to consider a very urgent referral for specialist assessment if an X-ray suggests the possibility of bone sarcoma, meaning an appointment within 48 hours.
NG12 also asks you to consider a very urgent direct access X-ray for a child or young person with unexplained bone swelling or pain, and it does not make an equivalent recommendation for adults.
The guideline defines its own terms: urgent means before 2 weeks, very urgent means within 48 hours, and a suspected cancer pathway referral means cancer diagnosed or ruled out within 28 days of referral.
For a soft tissue sarcoma rather than a bone sarcoma, NG12 asks for an urgent direct access ultrasound in adults with an unexplained lump that is increasing in size, and a very urgent one in children and young people.
Which X-ray features should make you suspect a bone sarcoma?
Four X-ray features should make you suspect a bone sarcoma: bone destruction, new bone formation, periosteal reaction or swelling, and soft tissue swelling.
Both the British Sarcoma Group and the June 2022 BOA Standard on metastatic bone disease list exactly those four, and both describe them as suggestive rather than diagnostic.
The British Sarcoma Group states that a plain X-ray is the first investigation of choice for a suspected bone sarcoma, taken in two planes at presentation.
Further local imaging of a suspected bone sarcoma should be with MRI, covering the whole anatomical compartment, the involved bone and the adjacent joints.
How should a suspicious bone lesion be investigated before referral?
Investigation before referral depends on age, because under 40 the question is bone sarcoma and over 40 the likelier answer is metastatic carcinoma or myeloma.
The British Sarcoma Group states that in patients under 40, investigations before referral should include X-ray of the affected bone in two planes plus full blood count, ESR and a biochemical profile including alkaline phosphatase.
In patients over 40 the same guideline suggests more extensive investigation before referral if it can be done quickly, including CT of the chest, abdomen and pelvis, an isotope bone scan and a myeloma screen.
The June 2022 BOA Standard asks for staging CT of the thorax, abdomen and pelvis within 24 hours of orthopaedic assessment when metastatic bone disease is suspected.
That same standard states that a staging CT without evidence of malignancy may indicate a primary bone tumour, and that this patient needs referral to a bone sarcoma centre within 72 hours.
What are the referral time targets for a suspected bone sarcoma?
The June 2022 BOA Standard sets 72 hours: a patient with radiographic features of a primary bone tumour should be referred to a bone sarcoma centre within 72 hours of the first suspicious or diagnostic imaging.
That standard defines a bone sarcoma centre as a specialised commissioned service for the management of bone sarcoma, and the British Sarcoma Group lists the UK reference centres by name.
The British Sarcoma Group adds that all patients with a possible diagnosis of a primary bone tumour should be referred urgently under the 2-week-wait pathway to a fully accredited bone sarcoma multidisciplinary team.
The same guideline states that referral before biopsy is essential, because poorly planned or executed biopsies can compromise future treatment of a bone sarcoma.
Why must a suspected bone sarcoma be biopsied at the centre?
A suspected bone sarcoma must be biopsied at the centre because the biopsy track becomes contaminated tissue that has to be excised with the tumour at definitive surgery.
The British Sarcoma Group states that biopsy should be carried out at a specialist sarcoma reference centre by, or in consultation with, the surgical team who will perform the definitive resection.
It states plainly that inappropriate biopsy can compromise limb salvage or even cure, which is the sentence to have ready if the panel pushes you on why the local surgeon should not do it.
The same guideline sets out biopsy principles: image the bone first to plan the approach, minimise contamination of normal tissue, and send samples for microbiology as well as histology and molecular studies.
The June 2022 BOA Standard says the same thing in one line: biopsy of a suspected primary bone tumour must be performed at a bone sarcoma centre.
What happens when a bone sarcoma is missed?
When a bone sarcoma is missed the consequences are a larger tumour, more extensive surgery and a worse chance of cure, and the British Sarcoma Group states that reducing delay would almost certainly improve survival.
Survival has not moved. The same guideline records 5-year overall survival for bone sarcomas static at between 53% and 55% over the past 25 to 30 years.
The specific orthopaedic disaster is fixing a pathological fracture through an undiagnosed bone sarcoma, which contaminates the whole bone and the implant track.
The British Sarcoma Group's position covers this: if there is diagnostic uncertainty, it should be assumed the patient has a primary bone sarcoma until proven otherwise.
What is the interviewer listening for on bone sarcoma?
The interviewer is listening for the words "refer before you biopsy" and for a bone sarcoma pathway with a number on it: 72 hours to the centre under the June 2022 BOA Standard.
They want the four X-ray features named, the night pain red flag stated, and an explicit acknowledgement that a normal radiograph does not exclude a bone sarcoma.
A strong candidate also splits the workup by age, because over 40 the commonest answer to a destructive bone lesion is metastatic carcinoma, not a primary bone sarcoma.
What are the common mistakes with suspected bone sarcoma?
The commonest mistake with a suspected bone sarcoma is biopsying it locally, which the British Sarcoma Group states can compromise limb salvage or even cure.
The second is reassuring a young patient because the X-ray looks normal, when the British Sarcoma Group specifically warns that persistent or night bone pain still needs urgent MRI or referral.
Others are attributing a child's knee pain to sport, treating a recent injury as an explanation, and internally fixing a suspicious pathological fracture before anyone has staged it.
How this comes up at the ST3 interview
A bone sarcoma arrives at the ST3 T&O clinical station as a radiograph with a periosteal reaction and a stem: a 16-year-old with six weeks of knee pain that wakes him at night.
The follow-ups are predictable: what concerns you on this film, what do you do next, who do you refer to and how quickly, and would you biopsy it yourself.
orthointerview's question bank puts this into station form with model answers and AI-marked spoken practice, across 782 questions and 100 scenarios, so the 72-hour target is said aloud before the day.